AXIM Stock - AXIM Biotechnologies, Inc.
Unlock GoAI Insights for AXIM
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $70,458 | $39,518 | $8,875 | $60,460 | N/A |
| Gross Profit | $-369,273 | $39,518 | $-417,251 | $60,460 | $-16,001 |
| Gross Margin | -524.1% | 100.0% | -4701.4% | 100.0% | N/A |
| Operating Income | $-1,763,079 | $-2,750,839 | $-4,652,772 | $-7,985,005 | $-4,948,998 |
| Net Income | $-3,512,466 | $-8,059,682 | $-5,956,966 | $-16,518,130 | $-6,730,693 |
| Net Margin | -4985.2% | -20395.0% | -67120.7% | -27320.8% | N/A |
| EPS | $-0.01 | $-0.04 | $-0.04 | $-0.13 | $-0.06 |
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. The company is developing rapid diagnostic tests, which measure the levels of functional neutralizing antibodies that prevent SARS-CoV-2 from attaching to human cells; serological diagnostic test, which detect neutralizing antibodies that measure adaptive immune response to the SARS-CoV-2 virus; and tests for management of COVID-19 Patients to detect biomarkers related to inflammation. It is also developing rapid quantitative tear tests for Matrix metalloproteinase-9, an inflammatory biomarker for dry eye disease; SBI-183, an anti-metastatic compound suppressing tumor cell growth and blocking metastasis; and SPX-1009, an anti-metastatic treatment to measure levels of quiescin sulfhydryl oxidase I. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
Visit WebsiteEarnings History & Surprises
AXIMEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 13, 2026 | — | — | — | — |
Q4 2025 | Nov 17, 2025 | — | — | — | — |
Q3 2025 | Aug 22, 2025 | — | — | — | — |
Q2 2025 | Apr 14, 2025 | — | $-0.00 | — | — |
Q4 2024 | Dec 31, 2024 | — | $-0.00 | — | — |
Q4 2024 | Nov 19, 2024 | — | $-0.00 | — | — |
Q3 2024 | Aug 19, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 20, 2024 | — | $-0.00 | — | — |
Q2 2024 | Apr 16, 2024 | — | $-0.01 | — | — |
Q4 2023 | Nov 20, 2023 | — | $0.00 | — | — |
Q3 2023 | Aug 21, 2023 | — | $-0.02 | — | — |
Q2 2023 | May 22, 2023 | — | $-0.02 | — | — |
Q2 2023 | Apr 17, 2023 | — | $0.00 | — | — |
Q4 2022 | Nov 15, 2022 | — | $-0.02 | — | — |
Q3 2022 | Aug 16, 2022 | — | $-0.01 | — | — |
Q2 2022 | May 23, 2022 | — | $-0.02 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.06 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.02 | — | — |
Q3 2021 | Aug 23, 2021 | — | $-0.03 | — | — |
Q2 2021 | May 24, 2021 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about AXIM
What is AXIM's current stock price?
What is the analyst price target for AXIM?
What sector is AXIM Biotechnologies, Inc. in?
What is AXIM's market cap?
Does AXIM pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to AXIM for comparison